<DOC>
	<DOC>NCT00485810</DOC>
	<brief_summary>The purpose of this study is to examine the clinical therapeutic dose in Japanese agitated patients with schizophrenia.</brief_summary>
	<brief_title>Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Male or female patients at least 20 years of age and less than 65 years old Patients must be inpatients during the study Patients must have a diagnosis of schizophrenia as per the DSMIV, as determined by the investigator Patients must be considered by the investigator to be clinically agitated and to be clinically appropriate candidates for the treatment with intramuscular (IM) medication Patients must have a minimum total score of greater than or equal to 14 on the 5 items of the PANSSEC and at least one individual item score of greater than or equal to 4 using the 17 scoring system, prior to the first IM injection of study drug Serious, unstable illnesses such that death is anticipated within 1 year or intensive care unit hospitalization for the disease is anticipated within 6 months. This includes hepatic (specifically any degree of jaundice), renal, gastroenterologic, respiratory, cardiovascular (including ischemic heart disease), endocrinologic, neurologic, immunologic, or hematologic diseases Known history of seizures; however, a patient whose etiology is identifiable and has been resolved may be enrolled Known history of diabetes mellitus, complications of diabetes mellitus, or potential diabetes mellitus as defined by patients with single blood glucose measurement based on site tests; patients with values greater than or equal to 140 mg/dL (nonfasting) or greater than or equal to 110 mg/dL (fasting) must be excluded from the study History of allergic reaction or intolerance to olanzapine Have received treatment with psychostimulants or reserpine within 1 week prior to study drug administration</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>